The global biochips market size reached US$ 16.9 Billion in 2022. Looking forward, the analyst expects the market to reach US$ 40.6 Billion by 2028, exhibiting a growth rate (CAGR) of 15.8% during 2023-2028. The growing prevalence of chronic diseases, increasing preferences for personalized medicines, and rising need for early detection of cancerous cells represent some of the key factors driving the market.
Biochips refer to a miniaturized medical device that is designed to perform several biochemical reactions simultaneously in less time. They comprise a collection of micro-test sites or microarrays, which are arranged on the surface of a solid substrate. They are widely available as deoxyribonucleic acid (DNA), protein, enzyme, and lab-on-a-chip. They are compact, powerful, fast, easy to use, and provide critical insights accurately. They are highly suitable for storing personal medical and financial information and can easily trace human beings or animals. They are implanted in the body and assist in monitoring, analyzing, and controlling the health of a patient and biological processes in the body. Besides this, they aid in identifying potential hazards, ensuring a safe environment, and improving decision-making. As a result, biochips find applications for gene, oncology, and inflammatory diagnosis and molecular analysis among individuals across the globe.
Biochips refer to a miniaturized medical device that is designed to perform several biochemical reactions simultaneously in less time. They comprise a collection of micro-test sites or microarrays, which are arranged on the surface of a solid substrate. They are widely available as deoxyribonucleic acid (DNA), protein, enzyme, and lab-on-a-chip. They are compact, powerful, fast, easy to use, and provide critical insights accurately. They are highly suitable for storing personal medical and financial information and can easily trace human beings or animals. They are implanted in the body and assist in monitoring, analyzing, and controlling the health of a patient and biological processes in the body. Besides this, they aid in identifying potential hazards, ensuring a safe environment, and improving decision-making. As a result, biochips find applications for gene, oncology, and inflammatory diagnosis and molecular analysis among individuals across the globe.
Biochips Market Trends:
At present, rising prevalence of chronic diseases, such as diabetes, blood pressure, and chronic obstructive pulmonary disease (COPD), represents one of the key factors supporting the growth of the market around the world. Besides this, the growing utilization of biochips in genomics, proteomics, and molecular diagnostics among the masses is positively influencing the market. Additionally, various benefits offered by biochips, such as reduction of time and money and the ability to provide high throughput without any requirement of heavy instruments, is contributing to the growth of the market. Apart from this, there is a rise in demand for time-saving and high-quality devices in the healthcare industry across the globe. This, coupled with the increasing preference for personalized medicines and next-generation sequencing (NGS) to treat numerous diseases among individuals, is propelling the growth of the market. In addition to this, the rising adoption of biochips for early detection of cancerous cells in the body is offering lucrative growth opportunities to industry investors. Moreover, the increasing geriatric population, along with the growing demand for biochips for drug development and discovery around the world, is offering a favorable market outlook. Furthermore, the biomedical advancement in microfluidic-based devices and innovation in lab-on-a-chip to offer quick results at initial diagnosis of infectious disease is impelling the growth of the market.Key Market Segmentation
The report provides an analysis of the key trends in each sub-segment of the global biochips market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, fabrication technique, analysis method, application and end user.Product Type Insights:
- DNA Chip
- Protein Chip
- Lab-On-a-Chip
- Enzyme Chip
Fabrication Technique Insights:
- Microarray
- Microfluidic
Analysis Method Insights:
- Electrophoresis
- Luminescence
- Mass Spectrometry
- Electrical Signals
- Magnetism
Application Insights:
- Molecular Analysis
- Hybridization
- Protein
- Immunological
- Biomolecules
- Biomarker
- Others
- Diagnosis
- Gene Diagnosis
- Oncology
- Inflammatory
- Others
- Non-Biological Usage
End User Insights:
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostics Centers
- Academic and Research Institutes
- Others
Regional Insights:
- North America
- United States
- Canada
- Europe
- Germany
- France
- United Kingdom
- Spain
- Russia
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Others
- Latin America
- Mexico
- Brazil
- Argentina
- Others
- Middle East and Africa
- Turkey
- Saudi Arabia
- United Arab Emirates
- Others
Competitive Landscape
The report has also provided a comprehensive analysis of the competitive landscape in the global biochips market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies, Inc., bioMérieux SA, Bio-RAD Laboratories, Inc., CapitalBio Corporation, Dynamic Biosensors GmbH, EMD Millipore Corporation, Fluidigm Corporation, Illumina, Inc., Perkinelmer, Inc., Thermo Fisher Scientific, Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.Key Questions Answered in This Report:
- How has the global biochips market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global biochips market?
- What is the impact of each driver, restraint, and opportunity on the global biochips market?
- What are the key regional markets?
- Which countries represent the most attractive biochips market?
- What is the breakup of the market based on the product type?
- Which is the most attractive product type in the biochips market?
- What is the breakup of the market based on the fabrication technique?
- Which is the most attractive fabrication technique in the biochips market?
- What is the breakup of the market based on the analysis method?
- Which is the most attractive analysis method in the biochips market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the biochips market?
- What is the breakup of the market based on the end user?
- Which is the most attractive end user in the biochips market?
- What is the competitive structure of the global biochips market?
- Who are the key players/companies in the global biochips market?
Table of Contents
1 Preface3 Executive Summary13 Value Chain Analysis
2 Scope and Methodology
4 Introduction
5 Global Biochips Market
6 Market Breakup by Product Type
7 Market Breakup by Fabrication Technique
8 Market Breakup by Analysis Method
9 Market Breakup by Application
10 Market Breakup by End User
11 Market Breakup by Region
12 SWOT Analysis
14 Porters Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Agilent Technologies Inc.
- bioMérieux SA
- Bio-RAD Laboratories Inc.
- CapitalBio Corporation
- Dynamic Biosensors GmbH
- EMD Millipore Corporation
- Fluidigm Corporation
- Illumina Inc.
- Perkinelmer Inc.,
- Thermo Fisher Scientific Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 144 |
| Published | October 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 16.9 Billion |
| Forecasted Market Value ( USD | $ 40.6 Billion |
| Compound Annual Growth Rate | 15.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
